WESPAC Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,095
Closed -$794K 164
2024
Q3
$794K Sell
5,095
-326
-6% -$52.6K 0.59% 58
2024
Q2
$846K Sell
5,421
-2,252
-29% -$339K 0.66% 53
2024
Q1
$1.04M Sell
7,673
-6,805
-47% -$901K 0.61% 54
2023
Q4
$1.95M Buy
14,478
+6,579
+83% +$855K 1.35% 15
2023
Q3
$1.07M Buy
7,899
+390
+5% +$53.3K 0.8% 44
2023
Q2
$1.07M Sell
7,509
-427
-5% -$62.8K 0.86% 41
2023
Q1
$1.1M Buy
+7,936
New +$1.07M 1.04% 32
2022
Q4
Sell
-7,208
Closed -$791K 67
2022
Q3
$791K Sell
7,208
-2,948
-29% -$374K 1.07% 35
2022
Q2
$1.34M Buy
+10,156
New +$1.33M 1.02% 31
2014
Q4
Sell
-12,395
Closed -$885K 122
2014
Q3
$885K Buy
12,395
+5,314
+75% +$389K 0.71% 60
2014
Q2
$526K Sell
7,081
-4,910
-41% -$355K 0.6% 66
2014
Q1
$778K Sell
11,991
-2,799
-19% -$181K 0.67% 64
2013
Q4
$878K Buy
14,790
+5,349
+57% +$291K 0.73% 56
2013
Q3
$490K Buy
+9,441
New +$474K 0.57% 69

Other funds holding AZN